Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicity.
Emily C LiangKai RejeskiTeng FeiAya AlbittarJennifer J HuangAndrew Jay PortugueseQian Vicky WuSandeep RajMarion SubkleweRoni ShouvalJordan GauthierPublished in: Bone marrow transplantation (2024)
Hematologic toxicity frequently complicates chimeric antigen receptor (CAR) T-cell therapy, resulting in significant morbidity and mortality. In an effort to standardize reporting, the European Hematology Association (EHA) and European Society of Blood and Marrow Transplantation (EBMT) devised the immune effector cell-associated hematotoxicity (ICAHT) grading system, distinguishing between early (day 0-30) and late (after day +30) events based on neutropenia depth and duration. However, manual implementation of ICAHT grading criteria is time-consuming and susceptible to subjectivity and error. To address these challenges, we introduce a novel computational approach, utilizing the R programming language, to automate early and late ICAHT grading. Given the complexities of early ICAHT grading, we benchmarked our approach both manually and computationally in two independent cohorts totaling 1251 patients. Our computational approach offers significant implications by streamlining grading processes, reducing manual time and effort, and promoting standardization across varied clinical settings. We provide this tool to the scientific community alongside a comprehensive implementation guide, fostering its widespread adoption and enhancing reporting consistency for ICAHT.
Keyphrases
- cell therapy
- healthcare
- stem cells
- primary care
- end stage renal disease
- mesenchymal stem cells
- single cell
- dendritic cells
- ejection fraction
- newly diagnosed
- mental health
- autism spectrum disorder
- quality improvement
- chronic kidney disease
- adverse drug
- peritoneal dialysis
- emergency department
- electronic health record
- type iii
- optical coherence tomography
- bone marrow